Evolus, Inc. (EOLS) Social Stream



Evolus, Inc. (EOLS): $9.54

-0.21 (-2.15%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

EVOLUS INC (EOLS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering EVOLUS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-13 7 $20 $7 $15.142 $10.39 45.74%
2022-01-27 6 $20 $7 $15.142 $10.39 45.74%
2022-03-04 7 $20 $7 $15.142 $10.39 45.74%
2022-04-21 7 $20 $7 $15.428 $10.39 48.49%
2022-04-28 7 $20 $8 $15.571 $10.39 49.87%
2022-05-11 6 $20 $8 $16 $10.39 53.99%
2022-05-12 6 $20 $10 $16.333 $10.39 57.2%
2022-10-13 7 $20 $10 $16.571 $10.39 59.49%
2022-11-02 6 $20 $10 $16.428 $10.39 58.11%
2022-11-09 7 $20 $10 $16.428 $10.39 58.11%
2023-01-19 7 $20 $10 $16.714 $10.39 60.87%

The Trend in the Analyst Price Target


EOLS's average price target has moved up $7.04 over the prior 24 months.

EOLS reports an average of 61.11% for its upside potential over the past 46 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-11 6 20 8 16.000 11.16 43.37%
2022-08-01 7 20 10 16.571 13.11 26.4%
2022-10-13 6 20 10 16.571 8.44 96.34%
2022-11-02 6 20 10 16.428 8.30 97.93%
2023-01-19 7 20 10 16.714 10.52 58.88%

EOLS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.43 5 1 1 0 0 7

The Trend in the Broker Recommendations


EOLS's average broker recommendation rating improved by 0 over the prior 153 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • EOLS has a higher average analyst price target than 268.76% of all US stocks.
  • In the context of all US stocks, EVOLUS INC's variance in analysts' estimates is lower than -945.39% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, EVOLUS INC's number of analysts covering the stock is greater than 1110.54% of them.
  • EOLS has a higher upside potential (average analyst target price relative to current price) than 432.42% of Pharmaceutical Products stocks.

Stocks similar to EVOLUS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ACET, KZIA, and VYNE.

Is EOLS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6578 seconds.